J 113863 |
| رقم الكتالوجGC14554 |
J 113863 هو مضاد CCR1 (CD18) قوي وانتقائي بقيم IC50 تبلغ 0.9 نانومتر و 5.8 نانومتر لمستقبلات CCR1 البشرية والفأرية ، على التوالي.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 353791-85-2
Sample solution is provided at 25 µL, 10mM.
منتجات GlpBio المذكورة في الأوراق ذات السمعة الطيبة
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Product Documents
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
| Cas No. | 353791-85-2 | SDF | |
| Chemical Name | (1r,4r)-1-((E)-cyclooct-1-en-1-ylmethyl)-4-(2,7-dichloro-9H-xanthene-9-carboxamido)-1-ethylpiperidin-1-ium iodide | ||
| Canonical SMILES | ClC1=CC=C(C(C(C2=C3)C(N[C@H]4CC[N@@+](C/C5=C/CCCCCC5)(CC)CC4)=O)=C1)OC2=CC=C3Cl.[I-] | ||
| Formula | C30H37Cl2IN2O2 | M.Wt | 655.44 |
| الذوبان | <65.54mg/ml in DMSO; <32.77mg/ml in ethanol | Storage | Store at -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
Complete Stock Solution Preparation Table
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 1.5257 mL | 7.6285 mL | 15.2569 mL |
| 5 mM | 0.3051 mL | 1.5257 mL | 3.0514 mL |
| 10 mM | 0.1526 mL | 0.7628 mL | 1.5257 mL |
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Related Products
- GC16866 Actinomycin D
- GN10151 Geraniin
- GC41722 (R,S)-Carvedilol Glucuronide
- GC17330 (+)-Usniacin
- GC40401 Prostaglandin F2α Alcohol methyl ether
- GC39568 EGFR-IN-8
- GC15670 Rabeprazole sodium
- GC44958 SU 5205
- GC15005 ONO 4817
- GC50508 PKUMDL WQ 2101
- GC61921 2,3-Dimethyl-2,3-diphenylbutane
- GC34276 5-Tamra-DRVYIHP
- GN10068 Patchouli alcohol
- GC15881 21-hydroxy Oligomycin A
- GC12216 Axitinib (AG 013736)
- GC33093 Decoyinine (Angustmycin A)
- GC31498 TP0463518
مراجعات
Average Rating: 5 ★★★★★ (Based on Reviews and 2 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *